News di Eurofins Italia

BioPharma News - 10a edizione

Eurofins presenta la nuova edizione della newsletter BioPharma NEWS. Gli articoli contenuti in questa edizione sono relativi ai servizi offerti dal gruppo Eurofins nell'ambito di: Eurofins Optimed - the leading partner in Early Clinical Development; Aerosol challenge for Container Closure Integrity studies; Genotoxicity tests for medical devices: what's new in ISO 10993-3: 2014?; EN ISO 22442 compliance for Virus Inactivation studies on Medical Devices using animal tissues and their derivatives; Implementation of 3R-principles by Eurofins partner laboratory BSL BIOSERVICE: Determination of in vivo starting dose with in vitro methods;Eurofins expands its GMP footprint in Spain.

BioPharma News - 10a edizione

Previous news

BioPharma News - 9a edizioneEurofins Chemical control: sugar alcohols contentEurofins BioPharma Product Testing vi invita alle giornate di studio: Emergenza ambiente - L'ecotossicologia come strumento di gestioneBioPharma News - 8a edizioneEurofins BioPharma Product Testing Product Hub_European_Pharmaceutical_review_magazineBioPharma News - 7a edizioneBioPharma news - 6a edizionePharma News - 5a edizioneAnnuncio acquisizone CTP LaboratoriesPharma News - 4a edizioneEurofins completes 2012 Laboratory Expansion PlanInternational Leaders Eurofins and MWH Global Complete Strategic Sale and Services Agreement for MWH LaboratoriesPharma News - 3a edizioneEurofins celebrates 25 years of laboratory excellenceEurofins strengthens Asia Pacific footprint with the acquisition of New Zealand Laboratory ServicesPharma News -2° edizioneEurofins Biolab al Simposio AFI 2012Eurofins reinforces leadership in the Brazilian testing marketEurofins reinforces leadership in the Benelux testing marketEurofins raises dividends and objectives for 2012Eurofins Biolab partecipa alla Fiera Expomed 2012Eurofins Enters Into an Agreement to Acquire QTA and a Supply Agreement with BASFPharma News - 1° edizioneEurofins leverages worldwide leadership to benefit the Food & Feed Industry with the launch of its Webinar ServicesEurofins achieved its aggressive objectives with strong earnings growth in 2011Eurofins Doubles Net Profit in the First Nine Months of 2011Eurofins announces successful closing of the transaction for a majority stake in IPL SED Nord and IPL InvestEurofins raises its sales and profit outlook for 2011 at its Annual Investor DayEurofins signs definitive agreement to acquire majority stakes in Institut Pasteur de Lille subsidiaries, IPL SED Nord and IPL InvestNantes Laboratory InaugurationEurofins highlights Asian presence to respond to calls for greater food safety levels in the regionStrong Growth and Operating Leverage Trebles Eurofins’ Net Profit in H1 2011Eurofins concludes loan issuance to further optimize balance sheetEurofins signs an exclusive agreement with the Fondation Institut Pasteur de Lille towards a partnership in the environmental testing fieldEurofins opens state-of-the-art high throughput laboratory for Radioactive Material Analysis in JapanEurofins at the forefront of Full Genome Sequencing for industryEurofins doubles dividends to shareholdersStrong Q1 topline growth provides solid start to 2011Allergen multi-screening in a single analysisEurofins announces successful closing of Lancaster acquisitionEurofins generates strong Free Cash Flows in 2010Eurofins signs agreement to acquire Lancaster Laboratories, IncEurofins reaffirms its mid-term objectivesDirettiva Attrezzature di lavoroAccreditamento CBTL (Certification Body Test Laboratory)iscrizione sostanzecontrolli micro
Aggiornato da: bdqu
Ultimo aggiornamento: venerdì 17 aprile 2015